1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECH
  4. SYNDAX PHARMACEUTICALS INC
Syndax Pharmaceuticals Inc XNAS: SNDX

Syndax Pharmaceuticals Inc Live Stock Price Today, Share Analysis and Chart

Momentum Trap
about

Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. Its product candidates include revumenib and axatilimab. It is developing revumenib, a ...

Read More
17.05 0.79 (4.86%)
98.72% Gain from 52W Low
758.9K
XNAS Volume

XNAS 28 Aug, 2025 10:37 AM (EDT)

Watchlist

Portfolio

Alert

Share
Durability score
Low Financial Strength
16.7 / 100
Valuation Score
Expensive Valuation
8.7 / 100
Momentum Score
Technically Moderately Bullish
60.1 / 100
Momentum Trap These stocks are with a bad quality and poor financial score ranging from medium to expensive valuation. Rising technical aspects may attract investors, but, weak financials cannot be overlooked. View Similar Embed DVM
Analyst Price Target
36
1Yr Price target upside is 113%
11 analysts

17

S

13

W

3

O

1

T

SWOT Analysis

Syndax Pharmaceuticals Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..